Egmidio Medina

8PUBLICATIONS
73CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 21, 2026
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

|Jan 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu

|Aug 26, 2025
Publisher Correction: Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu

|Aug 14, 2025
Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu

|Jul 02, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny.

Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters

|Oct 27, 2023
An NKG2A biased immune response confers protection for infection, autoimmune disease, and cancer.

James Heath, Daniel Chen, Jingyi Xie

Pageof 2

Frequent Collaborators

8 joint publications

Antoni Ribas

7 joint publications

Katie M Campbell

4 joint publications

Jia Ming Chen

4 joint publications

Alexandra P Ikeguchi